vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $106.2M, roughly 1.7× GRID DYNAMICS HOLDINGS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs 0.3%, a 0.6% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 5.9%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $6.1M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 15.3%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
FOLD vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $106.2M |
| Net Profit | $1.7M | $306.0K |
| Gross Margin | 85.7% | 34.0% |
| Operating Margin | 8.6% | 0.5% |
| Net Margin | 0.9% | 0.3% |
| Revenue YoY | 23.7% | 5.9% |
| Net Profit YoY | -88.5% | -93.2% |
| EPS (diluted) | $0.00 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $106.2M | ||
| Q3 25 | $169.1M | $104.2M | ||
| Q2 25 | $154.7M | $101.1M | ||
| Q1 25 | $125.2M | $100.4M | ||
| Q4 24 | $149.7M | $100.3M | ||
| Q3 24 | $141.5M | $87.4M | ||
| Q2 24 | $126.7M | $83.0M | ||
| Q1 24 | $110.4M | $79.8M |
| Q4 25 | $1.7M | $306.0K | ||
| Q3 25 | $17.3M | $1.2M | ||
| Q2 25 | $-24.4M | $5.3M | ||
| Q1 25 | $-21.7M | $2.9M | ||
| Q4 24 | $14.7M | $4.5M | ||
| Q3 24 | $-6.7M | $4.3M | ||
| Q2 24 | $-15.7M | $-817.0K | ||
| Q1 24 | $-48.4M | $-3.9M |
| Q4 25 | 85.7% | 34.0% | ||
| Q3 25 | 88.5% | 33.3% | ||
| Q2 25 | 90.2% | 34.1% | ||
| Q1 25 | 90.7% | 36.8% | ||
| Q4 24 | 90.1% | 36.9% | ||
| Q3 24 | 90.6% | 37.4% | ||
| Q2 24 | 91.1% | 35.6% | ||
| Q1 24 | 87.7% | 34.7% |
| Q4 25 | 8.6% | 0.5% | ||
| Q3 25 | 20.3% | -0.2% | ||
| Q2 25 | -6.1% | -0.1% | ||
| Q1 25 | -6.3% | -2.0% | ||
| Q4 24 | 10.7% | 1.3% | ||
| Q3 24 | 15.3% | 2.4% | ||
| Q2 24 | 11.8% | 0.0% | ||
| Q1 24 | -25.1% | -6.9% |
| Q4 25 | 0.9% | 0.3% | ||
| Q3 25 | 10.2% | 1.1% | ||
| Q2 25 | -15.8% | 5.2% | ||
| Q1 25 | -17.3% | 2.9% | ||
| Q4 24 | 9.8% | 4.5% | ||
| Q3 24 | -4.8% | 4.9% | ||
| Q2 24 | -12.4% | -1.0% | ||
| Q1 24 | -43.9% | -4.9% |
| Q4 25 | $0.00 | $0.01 | ||
| Q3 25 | $0.06 | $0.01 | ||
| Q2 25 | $-0.08 | $0.06 | ||
| Q1 25 | $-0.07 | $0.03 | ||
| Q4 24 | $0.05 | $0.06 | ||
| Q3 24 | $-0.02 | $0.05 | ||
| Q2 24 | $-0.05 | $-0.01 | ||
| Q1 24 | $-0.16 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $342.1M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $542.1M |
| Total Assets | $949.9M | $612.9M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $342.1M | ||
| Q3 25 | $263.8M | $338.6M | ||
| Q2 25 | $231.0M | $336.8M | ||
| Q1 25 | $250.6M | $325.5M | ||
| Q4 24 | $249.9M | $334.7M | ||
| Q3 24 | $249.8M | $231.3M | ||
| Q2 24 | $260.1M | $256.0M | ||
| Q1 24 | $239.6M | $249.4M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $542.1M | ||
| Q3 25 | $230.4M | $537.7M | ||
| Q2 25 | $204.3M | $532.2M | ||
| Q1 25 | $193.6M | $517.4M | ||
| Q4 24 | $194.0M | $517.8M | ||
| Q3 24 | $178.8M | $400.2M | ||
| Q2 24 | $132.5M | $388.4M | ||
| Q1 24 | $130.7M | $382.8M |
| Q4 25 | $949.9M | $612.9M | ||
| Q3 25 | $868.8M | $613.2M | ||
| Q2 25 | $815.3M | $608.9M | ||
| Q1 25 | $789.8M | $590.9M | ||
| Q4 24 | $785.0M | $592.2M | ||
| Q3 24 | $786.6M | $477.3M | ||
| Q2 24 | $749.5M | $443.6M | ||
| Q1 24 | $721.8M | $435.3M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $9.9M |
| Free Cash FlowOCF − Capex | $16.0M | $6.1M |
| FCF MarginFCF / Revenue | 8.6% | 5.7% |
| Capex IntensityCapex / Revenue | 0.2% | 3.6% |
| Cash ConversionOCF / Net Profit | 9.62× | 32.34× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $9.9M | ||
| Q3 25 | $35.7M | $7.0M | ||
| Q2 25 | $-26.5M | $14.4M | ||
| Q1 25 | $7.8M | $9.4M | ||
| Q4 24 | $-3.9M | $7.1M | ||
| Q3 24 | $-23.0M | $9.2M | ||
| Q2 24 | $22.7M | $10.7M | ||
| Q1 24 | $-29.7M | $3.2M |
| Q4 25 | $16.0M | $6.1M | ||
| Q3 25 | $35.3M | $2.9M | ||
| Q2 25 | $-28.9M | $10.2M | ||
| Q1 25 | $7.5M | $6.0M | ||
| Q4 24 | $-4.2M | $4.4M | ||
| Q3 24 | $-23.3M | $5.9M | ||
| Q2 24 | $21.6M | $8.0M | ||
| Q1 24 | $-31.5M | $43.0K |
| Q4 25 | 8.6% | 5.7% | ||
| Q3 25 | 20.9% | 2.8% | ||
| Q2 25 | -18.7% | 10.1% | ||
| Q1 25 | 6.0% | 6.0% | ||
| Q4 24 | -2.8% | 4.4% | ||
| Q3 24 | -16.5% | 6.8% | ||
| Q2 24 | 17.0% | 9.7% | ||
| Q1 24 | -28.5% | 0.1% |
| Q4 25 | 0.2% | 3.6% | ||
| Q3 25 | 0.2% | 3.9% | ||
| Q2 25 | 1.6% | 4.1% | ||
| Q1 25 | 0.2% | 3.3% | ||
| Q4 24 | 0.2% | 2.6% | ||
| Q3 24 | 0.3% | 3.7% | ||
| Q2 24 | 0.9% | 3.2% | ||
| Q1 24 | 1.6% | 4.0% |
| Q4 25 | 9.62× | 32.34× | ||
| Q3 25 | 2.06× | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | -0.27× | 1.56× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
GDYN
| Other | $30.6M | 29% |
| Technology Media And Telecom | $30.1M | 28% |
| Financial Service | $24.3M | 23% |
| Manufactured Product Other | $10.8M | 10% |
| Related Party | $7.6M | 7% |
| Health Care | $2.8M | 3% |
